524 related articles for article (PubMed ID: 17428002)
1. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
2. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of T and Tn epitopes on chronic lymphocytic leukemia cells.
Aller CT; Kucuk O; Springer GF; Gilman-Sachs A
Am J Hematol; 1996 May; 52(1):29-38. PubMed ID: 8638608
[TBL] [Abstract][Full Text] [Related]
5. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
[TBL] [Abstract][Full Text] [Related]
6. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
[TBL] [Abstract][Full Text] [Related]
7. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
9. Adhesion molecules in B-chronic lymphoproliferative disorders.
Angelopoulou MK; Kontopidou FN; Pangalis GA
Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
[TBL] [Abstract][Full Text] [Related]
10. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23.
Dorfman DM; Pinkus GS
Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704
[TBL] [Abstract][Full Text] [Related]
11. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
Molica S; Mannella A; Crispino G; Dattilo A; Levato D
Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
13. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase.
Bell PB; Rooney N; Bosanquet AG
Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328
[TBL] [Abstract][Full Text] [Related]
14. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
15. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
[TBL] [Abstract][Full Text] [Related]
16. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
17. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
Dunphy CH; Wheaton SE; Perkins SL
Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders.
Milosević D; Marinković M; Jelić S; Colović M; Spuzić I
Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680
[TBL] [Abstract][Full Text] [Related]
19. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
20. [Study of the characteristics of various hematologic diseases using monoclonal antibodies LT1, LT2 and LT7].
Filatov AV; Tsveĭbakh AS; Kazhdan IIa; Bachurin PS; Klubovskaia NI
Ter Arkh; 1989; 61(2):104-8. PubMed ID: 2786260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]